"Mom Pooch" Isn't Fat — What Diastasis Recti Actually Is (and What the Peptide Claims Get Wrong)

Diastasis recti affects roughly two out of three postpartum women, and it is routinely misread as "just baby weight that hasn't come off." It isn't fat. It's a structural separation of the abdominal muscles along the linea alba, the connective tissue running down the midline of the stomach, stretched during pregnancy and, in a majority of cases, never fully closing back up on its own.

What Diastasis Recti Actually Is

The gap sits between the left and right rectus abdominis muscles. When it's wide enough, the connective tissue behind it can no longer hold the abdominal wall flat, which is what produces the visible "pooch" — a bulge that shows up regardless of body fat percentage, gets worse with certain movements (sitting up from lying down is the classic trigger), and does not respond to calorie restriction or crunches. Core stabilization exercises done correctly, and in more significant cases physical therapy or an abdominal binder during recovery, are the interventions with actual clinical support behind them — a clinical trial specifically testing abdominal corset use alongside core stabilization exercises for postpartum diastasis is registered and underway, which tells you this is still an active, unsettled area of research even for the well-established treatments.

Where BPC-157 Enters the Conversation

BPC-157 has started showing up in postpartum recovery content, usually grouped with GHK-Cu and Thymosin Beta-4 under a general "tissue repair" banner. The mechanism being pointed to is real in one narrow sense: BPC-157 has shown measurable effects on tissue reattachment in animal studies, including a rat study on surgical muscle-to-bone reattachment. What that is not is evidence that BPC-157 does anything specific for a stretched linea alba in a human postpartum body — that study, and most of what currently exists, is preclinical. We've gone deeper on this in BPC-157's Human Evidence Gap; the short version applies here too: promising mechanism, not a demonstrated fix for this specific problem.

Where GHK-Cu Enters the Conversation

GHK-Cu gets attached to this pain point differently — not for the muscle separation itself, but for the skin laxity that often comes with it (the "loose skin" half of the same conversation). GHK-Cu's collagen-stimulating mechanism is genuinely well-documented in skin research generally. Whether that translates into a meaningful difference for postpartum abdominal skin specifically, at the doses and timelines people are actually using, is a separate question with a thinner answer — we cover that gap in GHK-Cu Is Trending Fast — Here's What the Actual Science Says.

Where TB-500 Enters the Conversation

TB-500 (Thymosin Beta-4) is the third compound usually grouped into this same "tissue repair" trio. Its evidence base follows the same shape as BPC-157's — real signal in tissue-repair and cell-migration research, but not a human study specific to diastasis recti or postpartum core recovery. Same caveat, same recommendation: mechanistically plausible, not a proven fix for this exact problem.

What This Means Practically

If diastasis recti is the actual issue, the evidence-backed starting point is a physical therapy evaluation — a pelvic floor or postpartum-specialized PT can measure the actual gap and prescribe the right stabilization exercises — not a peptide protocol as a first move. If you're researching compounds as a longer-term or complementary interest once that groundwork is in place, the honest position is: mechanistically plausible, not proven for this specific use, and worth treating that distinction as real rather than marketing noise. Whichever of the three above you're actually looking into, each has its live per-supplier pricing tracked on its own page here — check what you'd actually be buying and from whom before you buy it, not after.